---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020651"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:56:35.996998+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs closes $3M senior secured convertible notes with warrants at $0.50

## Summary
- Notes have 20% original issue discount, secured by Company assets, not convertible for first 4 months.
- Investors also receive warrants exercisable at $0.50 per share; up to $3M additional notes available.
- Proceeds for working capital, general corporate purposes, and repayment of certain existing debt.
- CEO cites potential near-term liquidity events: up to $50M COVID AR collection and possible Nebula Genomics sale.
- Company exploring reverse merger crypto treasury strategy leveraging Nebula's blockchain expertise.

## SEC filing metadata
- accession: 0001641172-25-020651
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000164117225020651/0001641172-25-020651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000164117225020651/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020651
- JSON: https://secwatch.observer/filing/0001641172-25-020651.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.